ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma

Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

(2012) Bertrand Coiffier et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment of Older Patients with Mantle-Cell Lymphoma

(2012) H.C. Kluin-Nelemans et al.   NEW ENGLAND JOURNAL OF MEDICINE

Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)

(2011) E. Jantunen et al.   ANNALS OF ONCOLOGY

An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma

(2011) T. E. Witzig et al.   ANNALS OF ONCOLOGY

Peripheral T-cell lymphoma

(2011) F. M. Foss et al.   BLOOD

Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis

(2011) S. L. Ondrejka et al.   HAEMATOLOGICA

Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert’s personal archive

(2011) Claudio Agostinelli et al.   HISTOPATHOLOGY

Mantle Cell Lymphoma International Prognostic Index but Not Pretransplantation Induction Regimen Predicts Survival for Patients With Mantle-Cell Lymphoma Receiving High-Dose Therapy and Autologous Stem-Cell Transplantation

(2011) Lihua E. Budde et al.   JOURNAL OF CLINICAL ONCOLOGY

Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study

(2011) Owen A. O'Connor et al.   JOURNAL OF CLINICAL ONCOLOGY

Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study

(2011) Stephen M Ansell et al.   LANCET ONCOLOGY

Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect

(2011) A Dodero et al.   LEUKEMIA

Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified

(2011) Pier Luigi zinzani et al.   LEUKEMIA & LYMPHOMA

Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type

(2011) Daisuke Ennishi et al.   LEUKEMIA & LYMPHOMA

The complex landscape of genetic alterations in mantle cell lymphoma

(2011) Cristina Royo et al.   SEMINARS IN CANCER BIOLOGY

Treatment of Elderly Patients With Mantle Cell Lymphoma

(2011) Hanneke C. Kluin-Nelemans et al.   SEMINARS IN HEMATOLOGY

Treatment of Younger Patients With Mantle Cell Lymphoma

(2011) Stéphanie Harel et al.   SEMINARS IN HEMATOLOGY

Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for Relapsed and Refractory Mantle Cell Lymphoma (MCL): A Study of the British Society for Blood and Marrow Transplantation

(2010) Gordon Cook et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era

(2010) P. Perez-Galan et al.   BLOOD

Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling

(2010) E. M. Hartmann et al.   BLOOD

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

(2010) N. Schmitz et al.   BLOOD

Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials

(2010) I Choi et al.   BONE MARROW TRANSPLANTATION

Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma

(2010) Francesco D’Amore et al.   BRITISH JOURNAL OF HAEMATOLOGY

Interim report of a phase 2 clinical trial of lenalidomide for T-cell non-Hodgkin lymphoma

(2010) Greg Dueck et al.   CANCER

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

(2010) V. Fernandez et al.   CANCER RESEARCH

Mantle cell lymphoma: The promise of new treatment options

(2010) Andre Goy et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Therapeutic concepts in mantle cell lymphoma

(2010) Jose Rodriguez et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

A novel subset of T-helper cells: follicular T-helper cells and their markers

(2010) C. Laurent et al.   HAEMATOLOGICA

Validation, revision and extension of the Mantle Cell Lymphoma International Prognostic Index in a population-based setting

(2010) S. A. M. van de Schans et al.   HAEMATOLOGICA

Front-line treatment of mantle cell lymphoma

(2010) C. H. Geisler   HAEMATOLOGICA

Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma

(2010) Jia Ruan et al.   JOURNAL OF CLINICAL ONCOLOGY

Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen

(2010) Sotirios Sachanas et al.   LEUKEMIA & LYMPHOMA

The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project

(2009) J. Suzumiya et al.   ANNALS OF ONCOLOGY

Significant efficacy of 2-CdA with or without rituximab in the treatment of splenic marginal zone lymphoma (SMZL)

(2009) G. Cervetti et al.   ANNALS OF ONCOLOGY

Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type

(2009) A. Stathis et al.   ANNALS OF ONCOLOGY

Allogeneic Stem Cell Transplantation for Patients with Relapsed Chemorefractory Aggressive Non-Hodgkin Lymphomas

(2009) Mehdi Hamadani et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma

(2009) C. S. Tam et al.   BLOOD

How I treat mantle cell lymphoma

(2009) M. Ghielmini et al.   BLOOD

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)

(2009) C. H. Geisler et al.   BLOOD

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

(2009) C. Pott et al.   BLOOD

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

(2009) J. Iqbal et al.   BLOOD

Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma

(2009) M. Dictor et al.   HAEMATOLOGICA

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype

(2009) A. Mozos et al.   HAEMATOLOGICA

Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma

(2009) Niels S. Andersen et al.   JOURNAL OF CLINICAL ONCOLOGY

Allogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma: A Retrospective Study From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

(2009) Charalampia Kyriakou et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

(2009) Georg Hess et al.   JOURNAL OF CLINICAL ONCOLOGY

Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

(2009) Massimo Federico et al.   JOURNAL OF CLINICAL ONCOLOGY

The simplified mantle cell lymphoma international prognostic index predicts overall survival but not progression-free survival in patients with mantle cell lymphoma treated with fludarabine and cyclophosphamide±rituximab: results of a randomized phase II trial

(2009) Heather E. Eve et al.   LEUKEMIA & LYMPHOMA

A novel regimen combining high dose cytarabine and bortezomib has activity in multiply relapsed and refractory mantle cell lymphoma – long-term results of a multicenter observation study

(2009) Oliver Weigert et al.   LEUKEMIA & LYMPHOMA

Hemopoietic stem cell transplantation in T-cell malignancies: Who, when, and how?

(2009) Francesco d’Amore et al.   Current Hematologic Malignancy Reports

Current treatment standards and emerging strategies in mantle cell lymphoma

(2009) M. Dreyling et al.   Hematology-American Society of Hematology Education Program

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study

(2008) A. Goy et al.   ANNALS OF ONCOLOGY

Allogeneic Transplantation with Reduced-Intensity Conditioning for Hodgkin and non-Hodgkin Lymphoma: Importance of Histology for Outcome

(2008) Philippe Armand et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Mantle Cell International Prognostic Index (MIPI) not prognostic after R-hyper-CVAD

(2008) J. J. Shah et al.   BLOOD

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

(2008) K. J. Savage et al.   BLOOD

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

(2008) C. H. Geisler et al.   BLOOD

Advances in the understanding of mantle cell lymphoma

(2008) Pedro Jares et al.   BRITISH JOURNAL OF HAEMATOLOGY

High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis

(2008) M. Dungarwalla et al.   BRITISH JOURNAL OF HAEMATOLOGY

Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma

(2008) Stephen M. Ansell et al.   CANCER

Mantle cell lymphoma with aberrant expression of CD10

(2008) U Zanetto et al.   HISTOPATHOLOGY

Five-Gene Model to Predict Survival in Mantle-Cell Lymphoma Using Frozen or Formalin-Fixed, Paraffin-Embedded Tissue

(2008) Elena Hartmann et al.   JOURNAL OF CLINICAL ONCOLOGY

International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes

(2008)   JOURNAL OF CLINICAL ONCOLOGY

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

(2008) Annina Herrmann et al.   JOURNAL OF CLINICAL ONCOLOGY

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

(2007) E. Hoster et al.   BLOOD